BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2021
View Archived Issues
Enrollment opens in phase IIa study of MK-1942 in treatment-resistant depression
Read More
Aprea begins enrollment in first-in-human study of APR-548 for TP53-mutated MDS
Read More
Prime, base editing are "finer scalpels" in dystrophy
Read More
APVO-442: a bispecific T-cell engager targeting PSMA and CD3 for treating prostate cancer
Read More
Proof of concept demonstrated with ABX-002 prodrug brain delivery of thyromimetic LL-340001
Read More
Zenshine compounds targeting E-NPP 1 have antitumor activity
Read More
Vaxart initiates enrollment in phase Ib boosting regimen trial of its norovirus vaccine
Read More
Revolo presents encouraging safety data for its peptide drug for allergic disease
Read More
Incyte discloses new CDK2/cyclin E inhibitors
Read More
BeiGene synthesizes STING modulators
Read More
BioCryst Pharmaceuticals presents complement factor D inhibitors
Read More
Cellectar Biosciences describes new phospholipid-drug conjugates for cancer
Read More
First healthy volunteers dosed in phase I/II study of HDT Bio's COVID-19 RNA vaccine in India
Read More
Fate Therapeutics patents new CARs for cancer immunotherapy
Read More
Betacellulin is a novel therapeutic target in schizophrenia
Read More
Positive topline data from GENESIS phase III study of motixafortide plus G-CSF in multiple myeloma
Read More
Kiniksa reports final data from first-in-human trial of KPL-404
Read More
New mutations in the SETX gene tied to ataxia with oculomotor apraxia type 2
Read More
Ascletis reports phase IIa data on ASC-22 for chronic hepatitis B
Read More
FDA clears IND for phase I/II study of Clarity's prostate cancer theranostic products
Read More
European Commission approves Sibnayal for distal renal tubular acidosis
Read More
Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209
Read More
SOM-3355 reduces chorea in patients with HD
Read More
Tecentriq approved in E.U. for first-line metastatic NSCLC with high PD-L1 expression
Read More